
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region: widening the mutation spectrum and searching for new pathogenic variants using next-generation methods - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="8E59E9529265C2433AE9520030629211.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="pore">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11324426/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Pathology and Oncology Research">
<meta name="citation_title" content="Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region: widening the mutation spectrum and searching for new pathogenic variants using next-generation methods">
<meta name="citation_author" content="László Baráti">
<meta name="citation_author_institution" content="Department of Medical Genetics, Clinical Centre, Medical School, University of Pécs, Pécs, Hungary">
<meta name="citation_author" content="Anita Maász">
<meta name="citation_author_institution" content="Department of Medical Genetics, Clinical Centre, Medical School, University of Pécs, Pécs, Hungary">
<meta name="citation_author" content="Alexandra Mikó">
<meta name="citation_author_institution" content="Department of Medical Genetics, Clinical Centre, Medical School, University of Pécs, Pécs, Hungary">
<meta name="citation_author_institution" content="Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary">
<meta name="citation_author" content="Éva Bércesi">
<meta name="citation_author_institution" content="Department of Oncotherapy, Clinical Centre, Medical School, University of Pécs, Pécs, Hungary">
<meta name="citation_author" content="Sultan Al Kalbani">
<meta name="citation_author_institution" content="Department of Medical Genetics, Clinical Centre, Medical School, University of Pécs, Pécs, Hungary">
<meta name="citation_author" content="Judit Bene">
<meta name="citation_author_institution" content="Department of Medical Genetics, Clinical Centre, Medical School, University of Pécs, Pécs, Hungary">
<meta name="citation_author" content="Sebestyén Kovács">
<meta name="citation_author_institution" content="Urology Clinic, Clinical Centre, University of Pécs, Pécs, Hungary">
<meta name="citation_author" content="László Mangel">
<meta name="citation_author_institution" content="Department of Oncotherapy, Clinical Centre, Medical School, University of Pécs, Pécs, Hungary">
<meta name="citation_author" content="Kinga Hadzsiev">
<meta name="citation_author_institution" content="Department of Medical Genetics, Clinical Centre, Medical School, University of Pécs, Pécs, Hungary">
<meta name="citation_publication_date" content="2024 Aug 1">
<meta name="citation_volume" content="30">
<meta name="citation_firstpage" content="1611813">
<meta name="citation_doi" content="10.3389/pore.2024.1611813">
<meta name="citation_pmid" content="39148954">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11324426/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11324426/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11324426/pdf/pore-30-1611813.pdf">
<meta name="description" content="Hereditary breast and ovarian cancer is a well-known genetic condition, inherited mainly in an autosomal dominant way, which elevates the risk of developing malignancies at a young age in heterozygous carriers. Advances in new generation sequencing ...">
<meta name="og:title" content="Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region: widening the mutation spectrum and searching for new pathogenic variants using next-generation methods">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Hereditary breast and ovarian cancer is a well-known genetic condition, inherited mainly in an autosomal dominant way, which elevates the risk of developing malignancies at a young age in heterozygous carriers. Advances in new generation sequencing ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11324426/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="11324426">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3389/pore.2024.1611813"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/pore-30-1611813.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11324426%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/11324426/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/11324426/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC11324426/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-pore.png" alt="Pathology and Oncology Research logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Pathology and Oncology Research" title="Link to Pathology and Oncology Research" shape="default" href="https://www.por-journal.com/journals/pathology-and-oncology-research" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Pathol Oncol Res</button></div>. 2024 Aug 1;30:1611813. doi: <a href="https://doi.org/10.3389/pore.2024.1611813" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3389/pore.2024.1611813</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Pathol%20Oncol%20Res%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pathol%20Oncol%20Res%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Pathol%20Oncol%20Res%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Pathol%20Oncol%20Res%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region: widening the mutation spectrum and searching for new pathogenic variants using next-generation methods</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bar%C3%A1ti%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">László Baráti</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">László Baráti</span></h3>
<div class="p">
<sup>1</sup>
Department of Medical Genetics, Clinical Centre, Medical School, University of Pécs, Pécs, Hungary
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bar%C3%A1ti%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">László Baráti</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ma%C3%A1sz%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Anita Maász</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Anita Maász</span></h3>
<div class="p">
<sup>1</sup>
Department of Medical Genetics, Clinical Centre, Medical School, University of Pécs, Pécs, Hungary
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ma%C3%A1sz%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Anita Maász</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mik%C3%B3%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Alexandra Mikó</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Alexandra Mikó</span></h3>
<div class="p">
<sup>1</sup>
Department of Medical Genetics, Clinical Centre, Medical School, University of Pécs, Pécs, Hungary
</div>
<div class="p">
<sup>2</sup>
Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mik%C3%B3%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alexandra Mikó</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22B%C3%A9rcesi%20%C3%89%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Éva Bércesi</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Éva Bércesi</span></h3>
<div class="p">
<sup>3</sup>
Department of Oncotherapy, Clinical Centre, Medical School, University of Pécs, Pécs, Hungary
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22B%C3%A9rcesi%20%C3%89%22%5BAuthor%5D" class="usa-link"><span class="name western">Éva Bércesi</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kalbani%20SA%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Sultan Al Kalbani</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Sultan Al Kalbani</span></h3>
<div class="p">
<sup>1</sup>
Department of Medical Genetics, Clinical Centre, Medical School, University of Pécs, Pécs, Hungary
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kalbani%20SA%22%5BAuthor%5D" class="usa-link"><span class="name western">Sultan Al Kalbani</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bene%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Judit Bene</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Judit Bene</span></h3>
<div class="p">
<sup>1</sup>
Department of Medical Genetics, Clinical Centre, Medical School, University of Pécs, Pécs, Hungary
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bene%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Judit Bene</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kov%C3%A1cs%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Sebestyén Kovács</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Sebestyén Kovács</span></h3>
<div class="p">
<sup>4</sup>
Urology Clinic, Clinical Centre, University of Pécs, Pécs, Hungary
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kov%C3%A1cs%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sebestyén Kovács</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mangel%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">László Mangel</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">László Mangel</span></h3>
<div class="p">
<sup>3</sup>
Department of Oncotherapy, Clinical Centre, Medical School, University of Pécs, Pécs, Hungary
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mangel%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">László Mangel</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hadzsiev%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Kinga Hadzsiev</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Kinga Hadzsiev</span></h3>
<div class="p">
<sup>1</sup>
Department of Medical Genetics, Clinical Centre, Medical School, University of Pécs, Pécs, Hungary
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hadzsiev%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kinga Hadzsiev</span></a>
</div>
</div>
<sup>1</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>
Department of Medical Genetics, Clinical Centre, Medical School, University of Pécs, Pécs, Hungary
</div>
<div id="aff2">
<sup>2</sup>
Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary
</div>
<div id="aff3">
<sup>3</sup>
Department of Oncotherapy, Clinical Centre, Medical School, University of Pécs, Pécs, Hungary
</div>
<div id="aff4">
<sup>4</sup>
Urology Clinic, Clinical Centre, University of Pécs, Pécs, Hungary
</div>
<div class="author-notes p">
<div class="fn" id="fn1_pmc"><p>
<strong>Edited by:</strong>
<a href="https://loop.frontiersin.org/people/701717/overview" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">József Tímár</a>, Semmelweis University, Hungary</p></div>
<div class="fn" id="c001">
<sup>✉</sup><p class="display-inline">*Correspondence: László Baráti, <span>barati.laszlo@pte.hu</span>
</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Apr 30; Accepted 2024 Jul 19; Collection date 2024.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2024 Baráti, Maász, Mikó, Bércesi, Kalbani, Bene, Kovács, Mangel and Hadzsiev.</div>
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC11324426  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39148954/" class="usa-link">39148954</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Hereditary breast and ovarian cancer is a well-known genetic condition, inherited mainly in an autosomal dominant way, which elevates the risk of developing malignancies at a young age in heterozygous carriers. Advances in new generation sequencing have enabled medical professionals to determine whether a patient is harbouring mutations in moderate- or high penetrance susceptibility genes. We conducted a retrospective analysis among 275 patients who underwent genetic counselling and multigene panel testing for hereditary breast and ovarian cancer syndrome in our department. From these patients 74.5% (205/275) were affected by some type of malignancy, while the remaining 25.5% (70/275) had a positive family history of different cancers, suggesting a genetic predisposition. These tests confirmed a genetic variant in 29.8% and 28.6% of these patient groups respectively. The results also mirrored our general knowledge concerning the genetic background of hereditary breast and ovarian cancer, as variants in either one of the <em>BRCA1</em> and <em>BRCA2</em> genes proved to be the most common cause among our patients with 41.5%. Our test also detected a novel mutation in the <em>CDH1</em> gene and three patients with double heterozygosity in two different susceptibility genes. This study demonstrates the relevance of genetic counselling and non-<em>BRCA</em> gene sequencing among cancer patients and patients who fulfil the criteria for genetic testing, while also providing important details about the genetic profile of Hungarian patients.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> HBOC, new generation sequencing, multigene panel testing, BRCA1, BRCA2</p></section></section><section id="s1"><h2 class="pmc_sec_title">Introduction</h2>
<p>Cancer is among the leading causes of mortality all over the world. Over the last decade, the incidence of malignancies has been growing worldwide, resulting in an estimated 20 million new cases and 9.7 million deaths in 2022. In most types of cancer, mortality has decreased due to preventive measures, improved diagnostic tests, screening programmes and more effective treatment options [<a href="#B1" class="usa-link" aria-describedby="B1">1</a>, <a href="#B2" class="usa-link" aria-describedby="B2">2</a>]. Unfortunately, predictions lead us to believe, that we can expect a steady increase in the number of new cases in the upcoming years [<a href="#B3" class="usa-link" aria-describedby="B3">3</a>].</p>
<p>In Hungary, breast cancer is the third most common malignancy after lung cancer and colorectal cancer, and the leading cause of cancer incidence in the female population, resulting in approximately 8,000 new cases and 2,000 deaths every year according to the Hungarian Cancer Registry [<a href="#B4" class="usa-link" aria-describedby="B4">4</a>].</p>
<p>Until recently, environmental causes were viewed as the main reason for the occurrence of malignancies. Akin to most multifactorial diseases, breast cancer is known to be associated with certain factors, that affect one’s risk to develop the disease in their lifetime. Modifiable risk factors include obesity, consumption of tobacco and alcohol, and taking hormones, while reproductive history, increasing age and a positive family history belong to non-modifiable risk factors [<a href="#B5" class="usa-link" aria-describedby="B5">5</a>–<a href="#B7" class="usa-link" aria-describedby="B7">7</a>].</p>
<p>In recent decades it has become apparent, that genetic variants play a considerable role in the development of breast- and ovarian cancer. While malignancies in general are usually a result of somatic mutations [<a href="#B8" class="usa-link" aria-describedby="B8">8</a>, <a href="#B9" class="usa-link" aria-describedby="B9">9</a>], approximately 5%–10% are caused by germline mutations in moderate- or high penetrance cancer susceptibility genes [<a href="#B10" class="usa-link" aria-describedby="B10">10</a>]. These predisposing genetic traits usually follow an autosomal dominant inheritance, leading to patients having a highly elevated cumulative risk of developing different types of malignancies, and a 50% chance of passing the mutation onto their offspring [<a href="#B11" class="usa-link" aria-describedby="B11">11</a>].</p>
<p>Over the last few decades, diagnosis of hereditary cancer syndromes has shown promising progress. With rapid advances in molecular testing and next-generation sequencing, a great number of individuals and families have been identified, who are affected by mutations in cancer susceptibility genes. While the BRCA-related hereditary breast- and ovarian cancer (HBOC) is among the most well-known tumour syndromes, one cannot skim over the importance of other, less common predisposition genes.</p>
<p>Due to a lack of data on genetic spectrum of the Hungarian HBOC population, we aimed to determine the prevalence of genetic variants of HBOC-associated genes in the Hungarian patient cohort and in healthy relatives with family history of cancer; to evaluate the associations of detected variants with clinical features; to evaluate how worthwhile it is to use a larger gene panel (including other genes beside <em>BRCA</em>s) in routine genetic diagnostics of Hungarians; and to evaluate the association between familial history of cancer and familial accumulation of the genetic variants in the cohort.</p></section><section id="s2"><h2 class="pmc_sec_title">Subjects and methods</h2>
<section id="s2-1"><h3 class="pmc_sec_title">Subjects</h3>
<p>The examinations related to this retrospective study were carried out in the Department of Medical Genetics in the University of Pécs. The patients and relatives that were involved into this study derived from the joint genetic counselling facility of Department of Medical Genetics and Department of Oncotherapy at the University of Pécs (Oncogenetic Counselling and Family Screening Centre). Patients’ data (personal history of cancer, tumour type, and age at diagnosis) were obtained from clinical records, while the family history of cancer was obtained from interviews with the probands. People referred to the genetic counselling went through a cancer genetic risk assessment. The purpose was to identify individuals at elevated cancer risk who may benefit from genetic testing, additional screening or preventive interventions. Using clues from the personal and family history, the genetic counsellor classified individuals as average (general population), increased (moderate), or high (strong) risk patients according to the widely accepted National Comprehensive Cancer Centre (NCCN) Clinical Practice Guidelines in Oncology, which are available online for experts<a href="#fn1" class="usa-link">
<sup>1</sup>
</a>. After risk assessment, individuals classified into the average risk level group were excluded from the study. We highlight the genetic risk stratification for HBOC in <a href="#T1" class="usa-link">Table 1</a>.</p>
<section class="tw xbox font-sm" id="T1"><h4 class="obj_head">TABLE 1.</h4>
<div class="caption p"><p>Genetic risk stratification for HBOC patients.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead valign="top"><tr>
<th align="left" rowspan="1" colspan="1">Risk level</th>
<th align="left" rowspan="1" colspan="1">Personal and family history evidence</th>
</tr></thead>
<tbody valign="top">
<tr>
<td rowspan="2" align="left" colspan="1">Average</td>
<td align="left" rowspan="1" colspan="1">No first- or second-degree relatives<a href="#Tfn1" class="usa-link">
<sup>a</sup>
</a> with breast or ovarian cancer; OR</td>
</tr>
<tr><td align="left" rowspan="1" colspan="1">More distant relatives with a breast cancer diagnosis or diagnoses after age 50</td></tr>
<tr>
<td rowspan="4" align="left" colspan="1">Increased (moderate)</td>
<td align="left" rowspan="1" colspan="1">Prior history of breast cancer, lobular neoplasia (LCIS/ALH), or atypical ductal hyperplasia</td>
</tr>
<tr><td align="left" rowspan="1" colspan="1">5-year risk ≥1.7% in women ≥35 years using the Gail model, or ≥20% lifetime risk defined by risk models</td></tr>
<tr><td align="left" rowspan="1" colspan="1">Thoracic radiotherapy &lt;30 years</td></tr>
<tr><td align="left" rowspan="1" colspan="1">One or two first- or second-degree relatives with breast cancer diagnosis after age 50</td></tr>
<tr>
<td rowspan="11" align="left" colspan="1">High (strong)</td>
<td align="left" rowspan="1" colspan="1">Known pathogenic variant (mutation) in the family</td>
</tr>
<tr><td align="left" rowspan="1" colspan="1">Somatic tumor testing suggesting a hereditary cancer syndrome</td></tr>
<tr><td align="left" rowspan="1" colspan="1">Patient or first-degree relative diagnosed with exocrine pancreatic cancer</td></tr>
<tr><td align="left" rowspan="1" colspan="1">Diagnosis in patient, or first- or second-degree relative with</td></tr>
<tr><td align="left" rowspan="1" colspan="1">breast cancer at age 45 or younger</td></tr>
<tr><td align="left" rowspan="1" colspan="1">triple negative breast cancer diagnosed at any age</td></tr>
<tr><td align="left" rowspan="1" colspan="1">multiple primary breast cancers</td></tr>
<tr><td align="left" rowspan="1" colspan="1">ovarian, certain prostate cancers, or male breast cancer at any age</td></tr>
<tr><td align="left" rowspan="1" colspan="1">breast cancer or prostate cancer diagnosis at any age and Ashkenazi<br>Jewish ancestry</td></tr>
<tr><td align="left" rowspan="1" colspan="1">Two or more first- or second-degree relatives on same side of family with breast cancer, if at least one was diagnosed ≤ age 50</td></tr>
<tr><td align="left" rowspan="1" colspan="1">Three or more total diagnoses of breast cancer in patient, first- or second-degree relatives on the same side of the family</td></tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="Tfn1">
<sup>
<sup>a</sup>
</sup><p class="display-inline">First-degree relatives are parents, children, and siblings. Second-degree relatives are grandparents, grandchildren, uncles and aunts.</p>
</div></div></section><p>Blood samples were taken from individuals with increased (moderate) and high (strong) risk for cancer and they were included in the study and for further examination. We collected 370 samples from patients with any cancer type. We classified the samples according to cancer types and we assorted 205 HBOC patients for further examination. Patients with other cancer types were excluded from the current analyses. Besides, we involved 70 healthy persons with a positive family history of HBOC-related cancer, e.g., breast, ovarian, prostate or pancreatic cancer into our examination.</p>
<p>All individuals gave their consent to genetic testing and biobanking, which were conducted following the WMA Declaration of Helsinki - Ethical principles for medical research involving human subjects (2013) and the Hungarian genetic law (XXI/2008). The study was approved by the Regional Research Ethics Committee of the University of Pécs (8770-PTE2021) and by the Medical Research Council (IV/3831-3/2021/EKU).</p></section><section id="s2-2"><h3 class="pmc_sec_title">Methods</h3>
<p>Whole peripheral blood samples were taken from all patients. DNA was extracted from the blood leukocytes using E.Z.N.A. Blood DNA Maxi Kit (Omega Biotek, Norcross, GA, United States) according to the protocol. QubitTM 2.0 Fluorometric Quantitation system (Thermo Fisher Scientific Inc., Waltham, MA United States) was used to calculate the quantity and quality of genomic DNA samples (Qubit™ 1X dsDNA HS (High Sensitivity) Assay Kits) according to the protocol. The DNA samples were deposited into the biobank of the department.</p>
<p>The patients were examined using Agilent SureMASTR Hereditary Cancer Kit previously, which was no longer manufactured (Agilent Technologies, Santa Clara, CA United States), thereafter we used TruSight Hereditary Cancer Kit (Illumina Inc., San Diego, CA United States). Both Kits are targeted sequencing panels. The SureMASTR Hereditary Cancer Kit contained 26 cancer-associated genes (<em>ATM</em>, <em>BARD1, BLM, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, EPCAM (3’UTR), FAM175A, MEN1, MLH1, MRE11A, MSH2, MSH6, MUTYH, NBN, PALB2, PMS2, PTEN, RAD50, RAD51C, RAD51D, STK11, TP53,</em> and <em>XRCC2</em>), the TruSight Hereditary Cancer Kit designed to assess germline mutations across 113 genes (<em>ACD, AIP, AKT1, APC, ATM, BAP1, BARD1, BLM, BMPR1A, BRCA1, BRCA2, BRIP1, CASR, CDC73, CDH1, CDK4, CDKN1B, CDKN2A, CEBPA, CHEK2, CTRC, DDB2, DICER1, DIS3L2, EPCAM, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, FAM175A, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, FH, FLCN, GALNT12, GATA2, GPC3, GREM1, HOXB13, KIF1B, KIT, LZTR1, MAX, MEN1, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MUTYH, NBN, NF1, NF2, NSD1, NTHL1, PALB2, PDGFRA, PHOX2B, PIK3CA, PMS2, POLD1, POLE, POT1, PRKAR1A, PTCH1, PTEN, RAD50, RAD51, RAD51B, RAD51C, RAD51D, RB1, RECQL4, RET, RHBDF2, RINT1, RUNX1, SDHA, SDHAF2, SDHB, SDHC, SDHD, SLX4, SMAD4, SMARCA4, SMARCB1, SMARCE1, SPINK1, SPRED1, STK11, SUFU, TERF2IP, TERT, TMEM127, TP53, TSC1, TSC2, VHL, WT1, XPA, XPC,</em> and <em>XRCC2</em>) commonly associated with hereditary predisposition to several cancers like breast, ovarian, colon, and gastric and tumour associated syndromes like tuberous sclerosis and neurofibromatosis. The SureMASTR Hereditary Cancer Kit assay uses amplicon sequencing method. The TruSight Hereditary Cancer Kit assay uses hybrid-capture chemistry integrated with Nextera Flex for Enrichment. We performed the assays according to the description of the manufacturer.</p>
<p>After sequencing reactions base called raw sequencing data was transformed into FASTQ format using Illumina’s software (bcl2fastq). Sequence reads of each sample were mapped to the human reference genome (GRCh37/hg19). Burrows-Wheeler Aligner (BWA-MEM) software was used for reading alignment. Duplicate read marking, local realignment around indels, base quality score recalibration and variant calling were performed using GATK algorithms (Sentieon Inc., California, United States). Variant data was annotated using a collection of tools (VcfAnno and VEP) with a variety of public variant databases including but not limited to gnomAD<a href="#fn2" class="usa-link">
<sup>2</sup>
</a>, ClinVar<a href="#fn3" class="usa-link">
<sup>3</sup>
</a> and HGMD<a href="#fn4" class="usa-link">
<sup>4</sup>
</a>. The variants detected were adapted to available public databases, depositories like Ensembl<a href="#fn5" class="usa-link">
<sup>5</sup>
</a>, Varsome<a href="#fn6" class="usa-link">
<sup>6</sup>
</a>, Franklin<a href="#fn7" class="usa-link">
<sup>7</sup>
</a>; and HGMD<a href="#fn8" class="usa-link">
<sup>8</sup>
</a> and were classified according to the latest guidelines and interpretation criteria established by the American College of Medical Genetics and Genomics. The variants received were matched to the clinical features of the patients and the persons with positive family history.</p>
<p>We used PCR for validation of variants detected by NGS. The accession numbers of the gene reference sequences applied for designing methods were summarized in <a href="#s11" class="usa-link">Supplementary Table S1</a> (<a href="#s11" class="usa-link">Supplementary Material</a>). For amplification of the region of interest, we designed specific primers (Integrated DNA Technologies Inc., Coralville, IA, United States) using the NCBI-PRIMER-BLAST tool (NCBI, Bethesda, MD, United States). The sequences of the applied oligonucleotide primers were summarized in <a href="#s11" class="usa-link">Supplementary Table S1</a> (<a href="#s11" class="usa-link">Supplementary Material</a>).</p>
<p>We performed PCR reactions according to the protocol below:</p>
<p>Final volume was 50 μL, which contained 200 µM of each dNTP (1 μL), 0.2 mM of each primer (1–1 μL), 5 μL of reaction buffer (containing 500 mM KCl, 10 mM Tris-HCl, 14 mmol/L MgCl2, pH 9.0), 1 U of Taq polymerase (1 μL of 10 U/µL) and 1 μg extracted DNA as template (1 μL). The conditions of the polymerase chain reactions for the detection of HBOC variants were as follows: initial denaturation at 96°C followed by 35 cycles of 30 s at 95°C; 30 s at the annealing temperature; 30 s at 72°C and a final extension at 72°C. The annealing temperatures applied for certain variants are indicated in <a href="#s11" class="usa-link">Supplementary Table S1</a> (<a href="#s11" class="usa-link">Supplementary Material</a>). The polymerase chain reactions were carried out using a SensoQuest Labcycler (SensoQuest GmBH, Göttingen, Germany).</p>
<p>After the amplification reaction, the products were electrophoresed through an ethidium-bromide-stained 1.5%–2% agarose gel and visualized by UVIdoc gel documentation system (UVITEC, Cambridge, UK).</p>
<p>The sequencing reactions were performed by Sanger sequencing on an Applied BiosystemsTM 3500 Genetic Analyzer (Thermo Fisher Scientific Inc., Waltham, MA, United States) using BigDye Terminator Chemistry. The sequence alignments were made using the Winstar genetic program (DNASTAR Inc., Madison, WI, United States).</p></section></section><section id="s3"><h2 class="pmc_sec_title">Results</h2>
<section id="s3-1"><h3 class="pmc_sec_title">General characterization</h3>
<p>We summarized the general characteristics of the study groups in <a href="#T2" class="usa-link">Table 2</a>. We have analysed a total of 275 samples with targeted next-generation sequencing panels of which, 205 agreed with HBOC criteria (HBOC cohort) and 70 were the sample of healthy persons with a positive family history of different cancers (non-HBOC cohort). The samples derived from non-consanguineous Hungarian people. HBOC patients’ data (age, tumour type and age at diagnosis) and non-HBOC person’s data were summarized in <a href="#T2" class="usa-link">Table 2</a>. Among the HBOC cases, 193 (94.1%) were females and 12 (5.85%) were males, all with a history of HBOC-related cancer. The average age of HBOC cases was 56.0 ± 15.0 years. The lowest age discovered was 21 years while the highest was 84 years. The average age at diagnosis for HBOC cases was 46.3 ± 11.7 years (range = 15–78 years). Among HBOC patients, 51.2% had their primary cancer diagnosis at age 45 years or younger. The types of cancers identified within the HBOC group were breast cancer (n = 179; 87.3%), ovarian cancer (n = 16; 7.81%), prostate cancer (n = 6; 2.93%), uterus cancer (n = 3; 1.47%) and endocervix cancer (n = 1; 0.49%).</p>
<section class="tw xbox font-sm" id="T2"><h4 class="obj_head">TABLE 2.</h4>
<div class="caption p"><p>Patient cohorts’ characteristics.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead valign="top"><tr><th colspan="2" align="left" rowspan="1">Cohort of HBOC patients<a href="#Tfn2" class="usa-link">
<sup>a</sup>
</a>
</th></tr></thead>
<tbody valign="top">
<tr><td colspan="2" align="left" rowspan="1">Gender n (%)</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1">Female</td>
<td align="left" rowspan="1" colspan="1">193 (94.1%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Male</td>
<td align="left" rowspan="1" colspan="1">12 (5.85%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">total</td>
<td align="left" rowspan="1" colspan="1">205</td>
</tr>
<tr><td colspan="2" align="left" rowspan="1">Age (years)</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1">Average ±SD</td>
<td align="left" rowspan="1" colspan="1">56.0 ± 15.0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Min–max</td>
<td align="left" rowspan="1" colspan="1">21–84</td>
</tr>
<tr><td colspan="2" align="left" rowspan="1">Age at diagnosis (years)</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1">Average ±SD</td>
<td align="left" rowspan="1" colspan="1">46.3 ± 11.7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Min–max</td>
<td align="left" rowspan="1" colspan="1">15–78</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">≤45</td>
<td align="left" rowspan="1" colspan="1">n = 105 (51.2%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">45–60</td>
<td align="left" rowspan="1" colspan="1">n = 70 (34.2%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">&gt;60</td>
<td align="left" rowspan="1" colspan="1">n = 30 (14.6%)</td>
</tr>
<tr><td colspan="2" align="left" rowspan="1">Tumour types n (%)</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1">Breast cancer</td>
<td align="left" rowspan="1" colspan="1">179 (87.3%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ovarian cancer</td>
<td align="left" rowspan="1" colspan="1">16 (7.81%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Uterus cancer</td>
<td align="left" rowspan="1" colspan="1">3 (1.47%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Prostate cancer</td>
<td align="left" rowspan="1" colspan="1">6 (2.93%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Endocervix</td>
<td align="left" rowspan="1" colspan="1">1 (0.49%)</td>
</tr>
<tr><td colspan="2" align="left" rowspan="1">Cohort of non-HBOC persons<a href="#Tfn3" class="usa-link">
<sup>b</sup>
</a>
</td></tr>
<tr><td colspan="2" align="left" rowspan="1">Gender n (%)</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1">Female</td>
<td align="left" rowspan="1" colspan="1">60 (85.7%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Male</td>
<td align="left" rowspan="1" colspan="1">10 (14.3%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">total</td>
<td align="left" rowspan="1" colspan="1">70</td>
</tr>
<tr><td colspan="2" align="left" rowspan="1">Age (years)</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1">Average ±SD</td>
<td align="left" rowspan="1" colspan="1">49.0 ± 14.0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Min–max</td>
<td align="left" rowspan="1" colspan="1">20–81</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="Tfn2">
<sup>
<sup>a</sup>
</sup><p class="display-inline">HBOC, cohort: hereditary breast and ovarian cancer.</p>
</div>
<div class="fn" id="Tfn3">
<sup>
<sup>b</sup>
</sup><p class="display-inline">non-HBOC: healthy persons with hereditary cancer relatives.</p>
</div>
</div></section><p>Among the healthy non-HBOC cases, there were 60 (85.7%) females and 10 (14.3%) males, all without personal breast and ovarian cancer history but with a positive family history of any cancer. The average age of non-HBOC cases was 49.0 ± 14.0 years, ranging from 20 to 81 years.</p>
<p>In <a href="#T3" class="usa-link">Table 3</a>, we summarized the distribution of genetic variants in all cohorts and the age at diagnosis in the HBOC cohort. The average age at diagnosis in the carrier HBOC group was 44.1 ± 10.9 years, where 25 years was the minimum and 72 years was the maximum age at diagnosis. The average age at diagnosis in non-carriers was 47.3 ± 11.9 years. The minimum age at diagnosis was 15 years; however, the maximum age at diagnosis was 78 years. There was no significant difference in the age at diagnosis between carrier and non-carrier HBOC groups.</p>
<section class="tw xbox font-sm" id="T3"><h4 class="obj_head">TABLE 3.</h4>
<div class="caption p"><p>Distribution of carriers and non-carriers in the cohorts.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead valign="top">
<tr>
<th colspan="3" align="left" rowspan="1"> </th>
<th colspan="2" align="left" rowspan="1">Age at diagnosis</th>
</tr>
<tr>
<th align="left" rowspan="1" colspan="1"></th>
<th align="center" rowspan="1" colspan="1"></th>
<th align="left" rowspan="1" colspan="1">Number of cases n (%)</th>
<th align="left" rowspan="1" colspan="1">Average ±SD (years)</th>
<th align="left" rowspan="1" colspan="1">Min–max (years)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="2" align="left" colspan="1">HBOC patients (n = 205)</td>
<td align="left" rowspan="1" colspan="1">Variant carriers</td>
<td align="left" rowspan="1" colspan="1">62 (29.8)</td>
<td align="left" rowspan="1" colspan="1">44.1 ± 10.9</td>
<td align="left" rowspan="1" colspan="1">25–72</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Non-carriers</td>
<td align="left" rowspan="1" colspan="1">143 (70.2)</td>
<td align="left" rowspan="1" colspan="1">47.3 ± 11.9</td>
<td align="left" rowspan="1" colspan="1">15–78</td>
</tr>
<tr>
<td rowspan="2" align="left" colspan="1">non-HBOC persons (n = 70)</td>
<td align="left" rowspan="1" colspan="1">Variant carriers</td>
<td align="left" rowspan="1" colspan="1">20 (28.6)</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Non-carriers</td>
<td align="left" rowspan="1" colspan="1">50 (71.4)</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
</tr>
<tr>
<td rowspan="2" align="left" colspan="1">All participants (n = 275)</td>
<td align="left" rowspan="1" colspan="1">Variant carriers</td>
<td align="left" rowspan="1" colspan="1">82 (29.8)</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Non-carriers</td>
<td align="left" rowspan="1" colspan="1">193 (70.2)</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="s3-2"><h3 class="pmc_sec_title">Mutational profile of HBOC and non-HBOC study groups</h3>
<p>The number of cases of HBOC patients carrying any genetic variants were 61, which is 29.8% of all HBOC patients tested. In the non-HBOC study group, 20 individuals were found carrying any genetic variant in association of cancer predisposition, which is 28.6% of the tested non-HBOC persons. The total number of all variant carriers was 82 cases, which is the 29.8% of all cases.</p>
<p>The complete record of the positive results of different tumour types is summarized in <a href="#T4" class="usa-link">Table 4</a>. The table shows the genes in which we detected variants and it contains the most prevalent variants, as well. Breast cancer was diagnosed in most of our cases (179/205; 87.3%), of which we identified genetic variants in 51 cases, representing 28.5% of the breast cancer patients: twelve <em>BRCA2</em> (6.70%), eight <em>CHEK2</em> (4.47%), eight <em>BRCA1</em> (4.47%), seven <em>ATM</em> (3.91%), three <em>PALB2</em> (1.68%), and 2-2 variants in <em>BARD1, FANCI</em> and <em>RAD51C</em> genes (1.12%), and 1-1 variant in <em>APC, BLM, CDH1, ERCC2, KIT, MSH6,, PMS2, RAD50, RAD51B,</em> and <em>RET</em> genes (0.56%). Besides, 9 out of 16 ovarian cancer cases (56.3%) harboured genetic variants: six <em>BRCA1</em> (37.5%), two <em>RAD51C</em> (12.5%) and in one case <em>BRCA2</em> (6.25%). The most prevalent variant was <em>BRCA1</em> c.5266dupC in the cohorts. Of the six prostate cancer cases, only one carried a genetic variant in the oncogenes (16.7%). From the three cases diagnosed with uterus cancer, only one case revealed positivity, where a pathogenic variant was found in the <em>BRCA1</em> gene. We could not detect any genetic alteration in the patients diagnosed with endocervix cancer by oncogenetic testing.</p>
<section class="tw xbox font-sm" id="T4"><h4 class="obj_head">TABLE 4.</h4>
<div class="caption p"><p>Carriers of pathogenic/likely pathogenic variants and variants of uncertain significance (VUS) according to tumour types in the HBOC cohort.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead valign="top"><tr>
<th align="left" rowspan="1" colspan="1">Tumour types</th>
<th align="left" rowspan="1" colspan="1">Gene<br>Variant detected</th>
<th align="left" rowspan="1" colspan="1">All carriers n (%)</th>
<th align="left" rowspan="1" colspan="1">Carriers of p/LP n (%)</th>
<th align="left" rowspan="1" colspan="1">Carriers of VUS n (%)</th>
</tr></thead>
<tbody valign="top">
<tr>
<td rowspan="21" align="left" colspan="1">Breast cancer (n = 179)</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">51 (28.5)</td>
<td align="left" rowspan="1" colspan="1">34 (19.0)</td>
<td align="left" rowspan="1" colspan="1">17 (9.50)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">12 (6.70)</td>
<td align="left" rowspan="1" colspan="1">9 (5.03)</td>
<td align="left" rowspan="1" colspan="1">3 (1.68)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="left" rowspan="1" colspan="1">8 (4.47)</td>
<td align="left" rowspan="1" colspan="1">8 (4.47)</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1 c.5266dupC</em>
</td>
<td align="left" rowspan="1" colspan="1">3 (1.68)</td>
<td align="center" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>CHEK2</em>
</td>
<td align="left" rowspan="1" colspan="1">8 (4.47)</td>
<td align="left" rowspan="1" colspan="1">7 (3.91)</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>CHEK2 c.599T&gt;C</em>
</td>
<td align="left" rowspan="1" colspan="1">3 (1.68)</td>
<td align="center" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>ATM</em>
</td>
<td align="left" rowspan="1" colspan="1">7 (3.91)</td>
<td align="left" rowspan="1" colspan="1">4 (2.23)</td>
<td align="left" rowspan="1" colspan="1">3 (1.68)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>PALB2</em>
</td>
<td align="left" rowspan="1" colspan="1">3 (1.68)</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
<td align="left" rowspan="1" colspan="1">2 (1.12)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BARD1</em>
</td>
<td align="left" rowspan="1" colspan="1">2 (1.12)</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>FANCI</em>
</td>
<td align="left" rowspan="1" colspan="1">2 (1.12)</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>RAD51C</em>
</td>
<td align="left" rowspan="1" colspan="1">2 (1.12)</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>APC</em>
</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BLM</em>
</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>CDH1</em>
</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>ERCC2</em>
</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>KIT</em>
</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>MSH6</em>
</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>PMS2</em>
</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>RAD50</em>
</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>RAD51B</em>
</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>RET</em>
</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">1 (0.56)</td>
</tr>
<tr>
<td rowspan="5" align="left" colspan="1">Ovarian cancer (n = 16)</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">9 (56.3)</td>
<td align="left" rowspan="1" colspan="1">7 (43.8)</td>
<td align="left" rowspan="1" colspan="1">2 (12.5)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="left" rowspan="1" colspan="1">6 (37.5)</td>
<td align="left" rowspan="1" colspan="1">5 (31.3)</td>
<td align="left" rowspan="1" colspan="1">1 (6.25)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em> c.5266dupC</td>
<td align="left" rowspan="1" colspan="1">3 (18.8)</td>
<td align="center" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>RAD51C</em>
</td>
<td align="left" rowspan="1" colspan="1">2 (12.5)</td>
<td align="left" rowspan="1" colspan="1">1 (6.25)</td>
<td align="left" rowspan="1" colspan="1">1 (6.25)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">1 (6.25)</td>
<td align="left" rowspan="1" colspan="1">1 (6.25)</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Prostate cancer (n = 6)</td>
<td align="left" rowspan="1" colspan="1">
<em>CHEK2</em>
</td>
<td align="left" rowspan="1" colspan="1">1 (16.7)</td>
<td align="left" rowspan="1" colspan="1">1 (16.7)</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Uterus cancer (n = 3)</td>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="left" rowspan="1" colspan="1">1 (33.3)</td>
<td align="left" rowspan="1" colspan="1">1 (33.3)</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Endocervix (n = 1)</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>The identified genetic variants in the HBOC and non-HBOC groups are listed in <a href="#s11" class="usa-link">Supplementary Table S2</a> (<a href="#s11" class="usa-link">Supplementary Material</a>). The table contains the clinical significance of the variants, which were predicted by the ClinVar database and Franklin interpretation tool. The clinical significance of most of the variants can be determined unanimously based on the data from ClinVar and Franklin. In some cases, there were discrepancies between the interpretation of ClinVar and Franklin (pathogenic-likely pathogenic, pathogenic-VUS). Based on the analysis, Franklin proved to be more permissive in most cases. In the ClinVar database, no records were found for the <em>CDH1</em> c.2499delT variant; however, after classification according to the ACMG guidelines, we interpreted it as a likely pathogenic/pathogenic variant, as was predicted by the Franklin prediction tool.</p>
<p>We identified pathogenic/likely pathogenic and VUS genetic variants in <em>APC, ATM</em>, <em>BARD1</em>, <em>BLM, BRCA1</em>, <em>BRCA2</em>, <em>CHEK2</em>, <em>CDH1</em>, <em>ERCC2, FANCI, KIT</em>, <em>MSH6</em>, <em>PALB2</em>, <em>PMS2</em>, <em>RAD50, RAD51B, RAD51C,</em> and <em>RET</em> in the HBOC group. The non-HBOC patients harbour pathogenic/likely pathogenic and VUS genetic variants in <em>BRCA1</em>, <em>BRCA2</em>, <em>CHEK2</em>, <em>EPCAM, ERCC3, FANCD2, MSH6</em>, <em>MUTYH, PALB2</em>, <em>POLE, PTCH1,</em> and <em>RAD51C.</em> Genetic variants in <em>BARD1</em>, <em>CDH1</em>, <em>PMS2</em>, <em>KIT</em> and <em>RET</em> genes were identified in HBOC patients only. Variants in <em>MUTYH</em>, <em>EPCAM</em>, <em>FANCD2</em>, <em>POLE</em>, <em>ERCC3,</em> and <em>PTCH1</em> were reported in the non-HBOC persons only. Overall, we identified 67 unique pathogenic/likely pathogenic variants and VUS carried by 82 individuals: 35 missense (52.2%), 15 frameshift (22.4%), 10 nonsense (14.9%), 2 synonymous (2.99%), 4 splice site variants (5.97%) and one three basepair deletion (1.49%), which cause one amino acid deletion, but not frameshift.</p>
<p>For <em>BRCA2</em>, 16 distinct variants in the association of cancer were identified in 17 individuals. The majority of the variants had pathogenic or likely pathogenic clinical significance. Only two variants were VUS (c.1012 G&gt;A; c.3042 T&gt;G). The most prevalent variant was the c.1408dupG, which were detected in two breast cancer cases, representing 2.98% of all variants detected.</p>
<p>For <em>BRCA1</em>, 10 different variants in association of cancer were identified in 17 individuals. Almost all variants were predicted to be pathogenic, and only one was predicted to be VUS (c.734 A&gt;T). In the case of c.845 C&gt;T, Franklin predicted it as VUS; however, it was mentioned as pathogenic in ClinVar. One of the variants (c.5266dupC) was present in seven samples, representing approximately 10.4% of all variants detected.</p>
<p>
<em>CHEK2</em> is the third gene, in which we most frequently identified variants in association with cancer. We detected 6 different variants in 11 individuals, from which five were pathogenic/likely pathogenic, one was VUS (c.1039 A&gt;G) and one had conflicting interpretations of pathogenicity (c.1684 C&gt;G; ClinVar: pathogenic/likely pathogenic, Franklin: VUS). One of the variants (c.599 T&gt;C) was present in six samples, representing approximately 8.96% of all variants detected.</p>
<p>For <em>ATM</em> gene, 7 distinct variants in the association of cancer were identified in 7 individuals, from which three were pathogenic/likely pathogenic and four were VUS according to ClinVar and Franklin.</p>
<p>We compared the numbers of detected cases and allele frequencies of the pathogenic/likely pathogenic variants for each gene in the study groups, which are summarized in <a href="#T5" class="usa-link">Table 5</a>. Pathogenic/likely pathogenic variants of <em>BRCA1</em> and <em>BRCA2</em> showed similar allele frequencies, which shared the highest frequencies among the genes in the HBOC cohort. In the non-HBOC group, <em>BRCA1</em> showed the highest frequency. Additionally, we assessed the allele frequencies of the genes in the gnomAD non-cancer cohort (n = 134 187), which showed significant differences in <em>BRCA1, BRCA2, CHEK2, MUTYH, MSH6, POLE, and ERCC3</em> genes in comparison to our non-HBOC groups.</p>
<section class="tw xbox font-sm" id="T5"><h4 class="obj_head">TABLE 5.</h4>
<div class="caption p"><p>Detection ratio of <em>BRCA1</em>, <em>BRCA2</em>, <em>PALB2</em>, <em>ATM</em>, <em>CHEK2</em>, <em>MUTYH</em>, <em>MSH6</em>, <em>RAD51C</em>, <em>BARD1</em>, <em>CDH1</em>, <em>POLE and ERCC3</em> P/LP variants in the study groups and gnomAD non-cancer population.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead valign="top">
<tr>
<th rowspan="2" align="left" colspan="1">Gene name</th>
<th colspan="2" align="left" rowspan="1">HBOC cohort (n = 205)</th>
<th colspan="2" align="left" rowspan="1">Non-HBOC cohort (n = 70)</th>
<th colspan="2" align="left" rowspan="1">All participants (n = 275)</th>
<th colspan="2" align="left" rowspan="1">GnomAD non-cancer cohort (n = 134 187)</th>
</tr>
<tr>
<th align="left" rowspan="1" colspan="1">Detected cases</th>
<th align="left" rowspan="1" colspan="1">Allele frequency</th>
<th align="left" rowspan="1" colspan="1">Detected cases</th>
<th align="left" rowspan="1" colspan="1">Allele frequency</th>
<th align="left" rowspan="1" colspan="1">Detected cases</th>
<th align="left" rowspan="1" colspan="1">Allele frequency</th>
<th align="left" rowspan="1" colspan="1">Detected cases</th>
<th align="left" rowspan="1" colspan="1">Allele frequency</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="left" rowspan="1" colspan="1">13</td>
<td align="left" rowspan="1" colspan="1">0.03170</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">0.02143<a href="#Tfn4" class="usa-link">
<sup>a</sup>
</a>
</td>
<td align="left" rowspan="1" colspan="1">16</td>
<td align="left" rowspan="1" colspan="1">0.02909</td>
<td align="left" rowspan="1" colspan="1">295</td>
<td align="left" rowspan="1" colspan="1">0.00110</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">13</td>
<td align="left" rowspan="1" colspan="1">0.03170</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">0.01429<a href="#Tfn4" class="usa-link">
<sup>a</sup>
</a>
</td>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">0.02727</td>
<td align="left" rowspan="1" colspan="1">411</td>
<td align="left" rowspan="1" colspan="1">0.00153</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>PALB2</em>
</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">0.00244</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">0.00182</td>
<td align="left" rowspan="1" colspan="1">200</td>
<td align="left" rowspan="1" colspan="1">0.00075</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>ATM</em>
</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">0.00730</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">0.00545</td>
<td align="left" rowspan="1" colspan="1">428</td>
<td align="left" rowspan="1" colspan="1">0.00160</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>CHEK2</em>
</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">0.01950</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">0.00714<a href="#Tfn4" class="usa-link">
<sup>a</sup>
</a>
</td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">0.01636</td>
<td align="left" rowspan="1" colspan="1">207</td>
<td align="left" rowspan="1" colspan="1">0.00077</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>MUTYH</em>
</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">0.01429<a href="#Tfn4" class="usa-link">
<sup>a</sup>
</a>
</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">0.00182</td>
<td align="left" rowspan="1" colspan="1">1,536</td>
<td align="left" rowspan="1" colspan="1">0.00572</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>MSH6</em>
</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">0.01429<a href="#Tfn4" class="usa-link">
<sup>a</sup>
</a>
</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">0.00363</td>
<td align="left" rowspan="1" colspan="1">119</td>
<td align="left" rowspan="1" colspan="1">0.00044</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>RAD51C</em>
</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">0.00244</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">0.00182</td>
<td align="left" rowspan="1" colspan="1">118</td>
<td align="left" rowspan="1" colspan="1">0.00044</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BARD1</em>
</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">0.00244</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">0.00182</td>
<td align="left" rowspan="1" colspan="1">84</td>
<td align="left" rowspan="1" colspan="1">0.00031</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>CDH1</em>
</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">0.00244</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">0.00182</td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">0.00003</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>POLE</em>
</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">0.00714<a href="#Tfn4" class="usa-link">
<sup>a</sup>
</a>
</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">0.00182</td>
<td align="left" rowspan="1" colspan="1">48</td>
<td align="left" rowspan="1" colspan="1">0.00018</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>ERCC3</em>
</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">0.00714<a href="#Tfn4" class="usa-link">
<sup>a</sup>
</a>
</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">0.00182</td>
<td align="left" rowspan="1" colspan="1">247</td>
<td align="left" rowspan="1" colspan="1">0.00092</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>FANCI</em>
</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">0.00244</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">0.00182</td>
<td align="center" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>ERCC2</em>
</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">0.00244</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">0.00182</td>
<td align="center" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BLM</em>
</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">0.00182</td>
<td align="center" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1"></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="fn5_pmc"><p>All individuals carried the variants in heterozygous form.</p></div>
<div class="fn" id="Tfn4">
<sup>
<sup>a</sup>
</sup><p class="display-inline">Chi-square tests were used for comparison of the allele frequencies between GnomAD, Non-Cancer Group and our non-HBOC, group.</p>
</div>
</div></section><p>Remarkably, <em>BRCA1</em> and <em>BRCA2</em> are the genes that explain almost half of the positive cases (17 + 17/82; 41.5%). <em>BRCA1</em> and <em>BRCA2</em> were the genes with the highest rate of pathogenic/likely pathogenic variants. Three patients diagnosed with breast cancer in the HBOC group harboured two genetic variants concomitantly (double heterozygotes; DH): 1. patient: <em>BRCA1</em> c.5266dupC het, p.Gln1756Profs*74 and <em>BLM</em> c.1642C&gt;T het, p.Gln548Ter, which are known pathogenic variants; the patient was diagnosed with Grade 3 triple negative, invasive ductal carcinoma at the age of 32 years. 2. patient: <em>BRCA2</em> c.7976G&gt;A het, p.Arg2659Lys and <em>RAD50</em> c.287T&gt;C het, p.Val96Ala, which are pathogenic and VUS, respectively; the patient has been receiving treatment for Grade 3 triple negative, invasive ductal carcinoma as well, which was diagnosed at the age of 29 years. 3. patient: <em>BRCA2</em> c.3042T&gt;G het, p.Asn1014Lys and <em>ATM</em> c.5890A&gt;G het, p.Lys1964Glu, which are VUSs. The patient was first diagnosed with Grade 3 triple negative invasive ductal carcinoma at the age of 35 years, and a contralateral Grade 3 triple negative ductal breast cancer at the age of 44 years. Though there were suspicions for causality based on the patient’s phenotype, the initial classification of these variants remained unchanged upon reevaluation.</p>
<p>Besides, we identified other variants with benign clinical significance by next-generation testing, which were not confirmed by Sanger sequencing and they are not the part of this study.</p></section></section><section id="s4"><h2 class="pmc_sec_title">Discussion</h2>
<p>Over the last decade, the spreading of new techniques such as NGS that allows the simultaneous analysis of multiple genes in panels as well as whole exome/genome are more cost-effective and efficient compared to Sanger sequencing. The use of these techniques probably contributes to faster recognition of the genetic cause of rare or ultra-rare disorders and to broadening the genetic screening of certain disorders, like cancers, where rapid diagnosis is extremely important for further care and the selection of appropriate therapy.</p>
<p>In our work, NGS allows us to determine the prevalence of genetic variants of HBOC-associated genes in the Hungarian patient cohort. Such data were not available for the Hungarian population, so far. We focused on the prevalence of genetic variants, predominantly pathogenic/likely pathogenic variants in cancer susceptibility genes in a Hungarian patient cohort selected from gathering increased (moderate) and high (strong) risk criteria for HBOC and a healthy individual’s cohort, whose family history was positive for any cancer.</p>
<p>Pathogenic/likely pathogenic variants and VUSs were found in almost 50% of all individuals in HBOC as well as in non-HBOC groups. We found variants in the following genes: <em>APC</em>, <em>ATM</em>, <em>BARD1</em>, <em>BLM</em>, <em>BRCA1</em> and <em>BRCA2, CDH1, CHEK2, EPCAM, ERCC3, FANCD2, KIT, MSH6, MUTYH, PALB2, PMS2, POLE, PTCH1, RAD, RAD51B, RAD51C,</em> and <em>RET.</em> These genes are involved in repairing DNA damage and maintaining the stability of the cell’s genetic material [<a href="#B12" class="usa-link" aria-describedby="B12">12</a>]. Some of these genes play important roles particularly in the homologous recombination-, base excision- and mismatch repair pathway (HRR, BER, MMR), which are important for maintaining genomic stability [<a href="#B13" class="usa-link" aria-describedby="B13">13</a>–<a href="#B15" class="usa-link" aria-describedby="B15">15</a>].</p>
<p>It is well-established that due to pathogenic germline variants detected in these genes, cells can grow uncontrolled and carrying these variants can confer predisposition for the development of hereditary cancer syndromes, which affects 5% of all HBOC cases. In the Hungarian HBOC group, <em>BRCA1</em> and <em>BRCA2</em> genes proved to be highly penetrant genes with their pathogenic detection rate of 6.34% (13/205, each). While <em>CHEK2</em> and <em>ATM</em> have moderate penetrance in HBOC (3.90%, 8/205; 1.46%, 3/205, respectively); in turn, the <em>PALB2</em> gene has a lower detection rate of 0.48% (1/205). These results are consistent with others’ findings in European populations with HBOC [<a href="#B16" class="usa-link" aria-describedby="B16">16</a>, <a href="#B17" class="usa-link" aria-describedby="B17">17</a>]. In the non-HBOC group, we obtained similar results regarding the <em>BRCA1</em> gene (4.29%, 3/70); however, there are differences in the prevalence of other genes. These differences can result from the fact, that in this group there were healthy people, who have a positive family history with a wide range of tumour spectrum including colorectal, pancreatic or gastric cancers, which have been associated with other genes such as <em>MUTYH</em> and <em>MSH6</em>.</p>
<p>Furthermore, the HBOC group was divided into subgroups according to the type of cancer: breast, ovarian, prostate, uterus and endocervix subgroups, and we evaluated the prevalence of genetic variants in each group. In the breast cancer subgroup, variants in <em>BRCA2</em> and <em>BRCA1</em> were the most frequently detected. In the ovarian cancer subgroup, <em>BRCA1</em> variants, mainly c.5266dupC was found. Besides, rare variants in other genes like <em>ATM</em>, <em>CHEK2</em>, <em>CDH1</em>, <em>PALB2</em>, <em>RAD50,</em> and <em>RAD51C</em> have been detected mainly in the breast cancer subgroup. Most of these variants detected are variants of uncertain significance (VUS). In clinical practice, VUSs represent a challenge, because they must be indicated on medical results; however, - according to ACMG recommendations - VUSs are not used to guide clinical management until the clarification of their exact role [<a href="#B18" class="usa-link" aria-describedby="B18">18</a>]. Almost all of the VUSs detected in the study are located within important regions of the genes or functional domains of the proteins and could affect biochemical properties and biological functions. Even though we cannot determine their clinical significance with current evidence, functional studies on these variants would be necessary to explore their phenotype consequences. In our study, these variants of uncertain significance account for high percentage of the positive cases, furthermore we detected a surprising number of pathogenic variants in moderate-, and low penetrant genes. There are differences among European countries in the judgement of involving low penetrance genes in the first-line genetic HBOC screening. In some countries (e.g., Austria, Estonia, Finland, Poland), the hotspot and/or founder variants of BRCA or HBOC genes are tested first. In other countries like Finland and the Netherland, WES is executed and evaluated as an oncogenetic panel. However, it may vary among laboratories within a given country. Our findings highlight the possible benefits of including other genes besides <em>BRCA</em>s in routine genetic testing. However, incorporation testing of several genes into multigene (<em>PMS2, RET, KIT</em>) for which the evidence of risk-association is weak or absent can result in information that might not be clinically relevant to the affected patients and their families [<a href="#B19" class="usa-link" aria-describedby="B19">19</a>, <a href="#B20" class="usa-link" aria-describedby="B20">20</a>].</p>
<p>In the Hungarian cohorts, the c.5266dupC in the <em>BRCA1</em> gene was detected most frequently (7/82, 8.54%). This variant is an insertion of one cytosine resulting in a frameshift and the creation of a novel translational termination codon after 74 amino acid residues. It is predicted to encode a truncated non-functional protein due to nonsense-mediated mRNA decay, which is a commonly known mechanism for disease. Functional studies have shown activity of the protein is significantly impaired by this variant [<a href="#B21" class="usa-link" aria-describedby="B21">21</a>]. This mutation has been described in individuals with HBOC, including individuals with male breast cancer, pancreatic cancer, and prostate cancer [<a href="#B22" class="usa-link" aria-describedby="B22">22</a>–<a href="#B27" class="usa-link" aria-describedby="B27">27</a>], and has been shown to be a founder mutation in several ethnic groups [<a href="#B28" class="usa-link" aria-describedby="B28">28</a>]. The high prevalence of this variant in our cohort and the fact that this variant has been reported several times in the literature state the probability of being a founder mutation of our population or maybe for a specific ethnicity; however, we did not collect information about the patient’s origin. To confirm this hypothesis, further studies are required.</p>
<p>To evaluate the association between familial history of cancer and accumulation of the genetic variants, we assessed allele frequency data between our non-HBOC group and the gnomAD non-cancer non-Finnish European population as a group of healthy (non-cancer) individuals without any family history of cancer [<a href="#B29" class="usa-link" aria-describedby="B29">29</a>]. The findings revealed significant differences in allele frequencies between the two study groups, so the healthy persons with elevated risk for cancer (because of positive family history) carry the pathogenic variants in a higher proportion than people in the average population. Generally, indications of testing for high-penetrance susceptibility genes include a personal history of cancer at a young age, triple-negative or male breast cancer, epithelial ovarian cancer, multiple primary malignancies, or a positive family anamnesis. Based on these facts, genetic screening of predisposing genes in healthy but elevated-risk persons would be necessary to prevent developing tumours. After screening, healthy carriers can be easily managed and can be involved in surveillance programs and preventive follow-up care. Recognizing at-risk patients who carry the aforementioned genetic variants has important consequences on an individual level and on a larger scale as well. Affected individuals, who are already undergoing treatment can receive targeted therapy based on their genetic results, which usually leads to better outcomes and higher probability of long-term survival. Since their risk for developing other malignancies is also elevated, a positive genetic result also warrants a multidisciplinary approach to their surveillance. Identification of healthy carriers offers patients an opportunity to attend regular screening from a young age and the possibility of certain, primary preventive measures, including chemoprevention and risk-reducing surgery [<a href="#B30" class="usa-link" aria-describedby="B30">30</a>–<a href="#B33" class="usa-link" aria-describedby="B33">33</a>]. These surveillance strategies lead to earlier detection and better prognosis, reducing premature mortality and prolonged disability, while also easing the strain of costs on the healthcare system.</p>
<p>Besides, we detected a novel germline variant (<em>CDH1</em> c.2499delT), which is not yet recorded in variant databases. We interpreted and classified this sequence variant according to the standards and guidelines published by the American College of Medical Genetics and Genomics and Association for Molecular Pathology (ACMG-AMP) [<a href="#B34" class="usa-link" aria-describedby="B34">34</a>, <a href="#B35" class="usa-link" aria-describedby="B35">35</a>]. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay resulting in an absent or non-functional protein product (PVS1). Other frameshift variants in the nearby region have been reported in individuals with hereditary cancer-predisposing syndrome, and Familial cancer of breast, loss-of-function of <em>CDH1</em> is a well-established mechanism leading to the disorder. This variant has not been observed in the large reference population cohorts of the Genome Aggregation Database (gnomAD, n &gt; 120 000 exomes and n &gt; 15 000 genomes) (PM2). To our knowledge, the variant has not been published in the relevant medical literature or reported in disease-related variation databases such as HGMD or ClinVar. To assess the impact of the missense change, we applied a combination of some of the most widely used “<em>in silico</em>” computational prediction tools like PolyPhen, Provean and MutationTaster [<a href="#B36" class="usa-link" aria-describedby="B36">36</a>]. These algorithms support obvious evidence that the c.2499delT variant is a protein damaging, disease-causing variant (PP3). To our best knowledge, there are no “<em>in vitro</em>” functional studies which investigate the damaging effect of this variant on the gene product (PS3). The classification of this <em>CDH1</em> variant provides strong evidence of pathogenicity. The patient was diagnosed with metastasizing lobular breast carcinoma at the age of 48 years. The histological subtype of her tumour suggests furthermore, that there is a cause-effect relation between her illness and the detected germline variant.</p>
<p>Double heterozygosity (DH) in a high-, or moderate penetrance gene is a rare event; however, its number is likely to increase due to the use of NGS. In our study, we report three breast cancer cases (3/205; 1.46%) with (1) two VUSs in <em>BRCA2</em> and <em>ATM</em> genes; (2) one pathogenic variant in the <em>BRCA2</em> gene and one VUS in the <em>RAD50</em> gene; (3) two pathogenic variant in <em>BRCA1</em> gene. Some studies showed no significant differences in risk for HBOC in DH carriers when compared with those carrying only one germline variant [<a href="#B37" class="usa-link" aria-describedby="B37">37</a>, <a href="#B38" class="usa-link" aria-describedby="B38">38</a>]. Others suggest that this genotype is not associated with early disease onset or a more severe phenotype [<a href="#B38" class="usa-link" aria-describedby="B38">38</a>]. In regards to our patients, all three were diagnosed with high grade, triple negative ductal carcinoma at a very young age. However, ethnic differences have been described as Caucasian DH females might develop breast cancer at an earlier age and have more severe disease in contrast to e.g., Ashkenazi Jewish females [<a href="#B37" class="usa-link" aria-describedby="B37">37</a>]. However, despite the little information about phenotype of DH carriers, we should not ignore their assumed risk modifier role and their possible cumulative impact on the development of the phenotype supporting a polygenic risk that should be considered in risk prediction in genetic counselling. Furthermore, DHs should be involved in more intensive surveillance programs/follow-up care and may need more severe prophylactic surgery [<a href="#B39" class="usa-link" aria-describedby="B39">39</a>].</p>
<p>The limitation of our study is the small number of individuals in certain groups with cancer types, which does not allow us to make profound genotype-phenotype associations. Besides, associations assumed in this study can be reliably assessed with information on other extrinsic contributing factors like smoking, alcohol consumption and dietary habits of the patients. These should be evaluated on a larger cohort of cancer patients.</p></section><section id="s5"><h2 class="pmc_sec_title">Conclusion</h2>
<p>The prevalence of hereditary mutations in breast, ovarian, endometrial and prostate cancer highlights the significance of genetic counselling and molecular genetic testing concerning these malignancies. Our study demonstrates a considerable percentage of pathogenic mutation carriers, emphasizing the benefits of molecular screening tests. The expansions of the diagnostic field revealed many other pathogenic variants associated with HBOC cancer that could have been missed if only <em>BRCA1</em> and <em>BRCA2</em> genes had been analysed. In this context, the appearance of next-generation sequencing methods has great potential. Thanks to its expansion, many new variants have been discovered in previously undiagnosed patients. Besides, comprehensive genetic diagnostics have long-term clinical benefits like increased patient cure rates, better patient surveillance, reduced cancer mortality rates, more effective treatments, and rapid recognition of high-risk families to reduce the risk of developing cancer. However, new challenges are generated in emerging next-generation sequencing like the interpretation of the huge amount of data derived from NGS, which highlights the need for highly skilled professionals in genetic counselling and molecular diagnostics with close cooperation of a multidisciplinary team.</p>
<p>Our results provide important new information to ethnic-specific cancer risk profiling and to determining even polygenic risk scores for HBOC, which can increase the sensitivity and specificity of cancer diagnostics as well as lowering the cost. However, several rare variants were identified with uncertain clinical significance, evaluation of the biological impact of these variants, further functional assays or robust segregation studies are needed.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work is supported (not financially) by the European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS). This study was supported by the Medical School of the University of Pécs, “ÁOK-KA” Research Program; KA-2023-22.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1">
<sup>1</sup><p class="display-inline">
<a href="http://www.nccn.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.nccn.org</a>
</p>
</div>
<div class="fn p" id="fn2">
<sup>2</sup><p class="display-inline">
<a href="https://gnomad.broadinstitute.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://gnomad.broadinstitute.org/</a>
</p>
</div>
<div class="fn p" id="fn3">
<sup>3</sup><p class="display-inline">
<a href="https://www.ncbi.nlm.nih.gov/clinvar/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/clinvar/</a>
</p>
</div>
<div class="fn p" id="fn4">
<sup>4</sup><p class="display-inline">
<a href="https://www.hgmd.cf.ac.uk/ac/index.php" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.hgmd.cf.ac.uk/ac/index.php</a>
</p>
</div>
<div class="fn p" id="fn5">
<sup>5</sup><p class="display-inline">
<a href="https://ensemble.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://ensemble.org</a>
</p>
</div>
<div class="fn p" id="fn6">
<sup>6</sup><p class="display-inline">
<a href="https://varsome.com/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://varsome.com/</a>
</p>
</div>
<div class="fn p" id="fn7">
<sup>7</sup><p class="display-inline">
<a href="https://franklin.genoox.com/clinical-db/home" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://franklin.genoox.com/clinical-db/home</a>
</p>
</div>
<div class="fn p" id="fn8">
<sup>8</sup><p class="display-inline">
<a href="http://www.hgmd.cf.ac.uk/ac/index.php" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.hgmd.cf.ac.uk/ac/index.php</a>
</p>
</div>
</div></section><section id="s6"><h2 class="pmc_sec_title">Data availability statement</h2>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<a href="#s11" class="usa-link">Supplementary Material</a>.</p></section><section id="s7"><h2 class="pmc_sec_title">Ethics statement</h2>
<p>The studies involving humans were approved by the Regional Research Ethics Committee of the University of Pécs (8770-PTE2021) and by the Medical Research Council (IV/3831-3/2021/EKU). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p></section><section id="s8"><h2 class="pmc_sec_title">Author contributions</h2>
<p>AnM and KH devised the main conceptual ideas and the outlines of the manuscript. AlM, LB, and KH conducted genetic counsultations, AnM and JB conducted sample preparation and genetic testing. Data collection about patient cohort and genetic results was performed mainly by SK. Patients of the cohort were referred to our institution by LM and EB as well. Manuscript written mainly by SK, AnM, AlM, LB, and KH. All authors contributed to the article and approved the submitted version.</p></section><section id="s10"><h2 class="pmc_sec_title">Conflict of interest</h2>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></section><section id="s11"><h2 class="pmc_sec_title">Supplementary material</h2>
<p>The Supplementary Material for this article can be found online at: <a href="https://www.por-journal.com/articles/10.3389/pore.2024.1611813/full#supplementary-material" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.por-journal.com/articles/10.3389/pore.2024.1611813/full#supplementary-material</a>
</p>
<section class="sm xbox font-sm" id="SM1"><div class="media p"><div class="caption">
<a href="/articles/instance/11324426/bin/DataSheet1.docx" data-ga-action="click_feat_suppl" class="usa-link">DataSheet1.docx</a><sup> (28.4KB, docx) </sup>
</div></div></section></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1">
<span class="label">1.</span><cite>
Mattiuzzi C, Lippi G. Current cancer epidemiology. J Epidemiol Glob Health (2019) 9(4):217–22. 10.2991/jegh.k.191008.001

</cite> [<a href="https://doi.org/10.2991/jegh.k.191008.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7310786/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31854162/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Epidemiol%20Glob%20Health&amp;title=Current%20cancer%20epidemiology&amp;author=C%20Mattiuzzi&amp;author=G%20Lippi&amp;volume=9&amp;issue=4&amp;publication_year=2019&amp;pages=217-22&amp;pmid=31854162&amp;doi=10.2991/jegh.k.191008.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2">
<span class="label">2.</span><cite>
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. 
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer J clinicians (2021) 71(3):209–49. 10.3322/caac.21660
</cite> [<a href="https://doi.org/10.3322/caac.21660" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33538338/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CA:%20a%20Cancer%20J%20clinicians&amp;title=Global%20cancer%20statistics%202020:%20GLOBOCAN%20estimates%20of%20incidence%20and%20mortality%20worldwide%20for%2036%20cancers%20in%20185%20countries&amp;author=H%20Sung&amp;author=J%20Ferlay&amp;author=RL%20Siegel&amp;author=M%20Laversanne&amp;author=I%20Soerjomataram&amp;volume=71&amp;issue=3&amp;publication_year=2021&amp;pages=209-49&amp;pmid=33538338&amp;doi=10.3322/caac.21660&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3">
<span class="label">3.</span><cite>
Garner WB, Smith BD, Ludmir EB, Wakefield DV, Shabason J, Williams GR, et al. 
Predicting future cancer incidence by age, race, ethnicity, and sex. J Geriatr Oncol (2023) 14(1):101393. 10.1016/j.jgo.2022.10.008

</cite> [<a href="https://doi.org/10.1016/j.jgo.2022.10.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36692964/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Geriatr%20Oncol&amp;title=Predicting%20future%20cancer%20incidence%20by%20age,%20race,%20ethnicity,%20and%20sex&amp;author=WB%20Garner&amp;author=BD%20Smith&amp;author=EB%20Ludmir&amp;author=DV%20Wakefield&amp;author=J%20Shabason&amp;volume=14&amp;issue=1&amp;publication_year=2023&amp;pages=101393&amp;pmid=36692964&amp;doi=10.1016/j.jgo.2022.10.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4">
<span class="label">4.</span><cite>
Nemzeti Rákregiszter. Nemzeti rákregiszter (2022). Available from: <a href="http://stat.nrr.hu/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://stat.nrr.hu/</a>
 (Accessed May 26, 2022).</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Nemzeti%20r%C3%A1kregiszter&amp;publication_year=2022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5">
<span class="label">5.</span><cite>
Howell A, Anderson AS, Clarke RB, Duffy SW, Evans DG, Garcia-Closas M, et al. 
Risk determination and prevention of breast cancer. Breast Cancer Res : BCR (2014) 16(5):446. 10.1186/s13058-014-0446-2

</cite> [<a href="https://doi.org/10.1186/s13058-014-0446-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4303126/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25467785/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res%20:%20BCR&amp;title=Risk%20determination%20and%20prevention%20of%20breast%20cancer&amp;author=A%20Howell&amp;author=AS%20Anderson&amp;author=RB%20Clarke&amp;author=SW%20Duffy&amp;author=DG%20Evans&amp;volume=16&amp;issue=5&amp;publication_year=2014&amp;pages=446&amp;pmid=25467785&amp;doi=10.1186/s13058-014-0446-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6">
<span class="label">6.</span><cite>
Kruk J, Aboul-Enein HY. Environmental exposure, and other behavioral risk factors in breast cancer. Curr Cancer Ther Rev (2006) 2:3–21. 10.2174/157339406775471795
</cite> [<a href="https://doi.org/10.2174/157339406775471795" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Cancer%20Ther%20Rev&amp;title=Environmental%20exposure,%20and%20other%20behavioral%20risk%20factors%20in%20breast%20cancer&amp;author=J%20Kruk&amp;author=HY%20Aboul-Enein&amp;volume=2&amp;publication_year=2006&amp;pages=3-21&amp;doi=10.2174/157339406775471795&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7">
<span class="label">7.</span><cite>
Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer (Dove Med Press) (2019) 11:151–64. 10.2147/BCTT.S176070

</cite> [<a href="https://doi.org/10.2147/BCTT.S176070" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6462164/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31040712/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20(Dove%20Med%20Press)&amp;title=Epidemiological%20characteristics%20of%20and%20risk%20factors%20for%20breast%20cancer%20in%20the%20world&amp;author=Z%20Momenimovahed&amp;author=H%20Salehiniya&amp;volume=11&amp;publication_year=2019&amp;pages=151-64&amp;pmid=31040712&amp;doi=10.2147/BCTT.S176070&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8">
<span class="label">8.</span><cite>
Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, et al. 
Patterns of somatic mutation in human cancer genomes. Nature (2007) 446(7132):153–8. 10.1038/nature05610

</cite> [<a href="https://doi.org/10.1038/nature05610" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2712719/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17344846/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Patterns%20of%20somatic%20mutation%20in%20human%20cancer%20genomes&amp;author=C%20Greenman&amp;author=P%20Stephens&amp;author=R%20Smith&amp;author=GL%20Dalgliesh&amp;author=C%20Hunter&amp;volume=446&amp;issue=7132&amp;publication_year=2007&amp;pages=153-8&amp;pmid=17344846&amp;doi=10.1038/nature05610&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9">
<span class="label">9.</span><cite>
Tate JG, Bamford S, Jubb HC, Sondka Z, Beare DM, Bindal N, et al. 
COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res (2019) 47(D1):D941–947. 10.1093/nar/gky1015

</cite> [<a href="https://doi.org/10.1093/nar/gky1015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6323903/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30371878/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res&amp;title=COSMIC:%20the%20catalogue%20of%20somatic%20mutations%20in%20cancer&amp;author=JG%20Tate&amp;author=S%20Bamford&amp;author=HC%20Jubb&amp;author=Z%20Sondka&amp;author=DM%20Beare&amp;volume=47&amp;issue=D1&amp;publication_year=2019&amp;pages=D941-947&amp;pmid=30371878&amp;doi=10.1093/nar/gky1015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10">
<span class="label">10.</span><cite>
Fan X, Wynn J, Shang N, Liu C, Fedotov A, Hallquist MLG, et al. 
Penetrance of breast cancer susceptibility genes from the eMERGE III Network. JNCI Cancer Spectr (2021) 5(4):pkab044. 10.1093/jncics/pkab044

</cite> [<a href="https://doi.org/10.1093/jncics/pkab044" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8346699/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34377931/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JNCI%20Cancer%20Spectr&amp;title=Penetrance%20of%20breast%20cancer%20susceptibility%20genes%20from%20the%20eMERGE%20III%20Network&amp;author=X%20Fan&amp;author=J%20Wynn&amp;author=N%20Shang&amp;author=C%20Liu&amp;author=A%20Fedotov&amp;volume=5&amp;issue=4&amp;publication_year=2021&amp;pages=pkab044&amp;pmid=34377931&amp;doi=10.1093/jncics/pkab044&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11">
<span class="label">11.</span><cite>
Garber JE, Offit K. Hereditary cancer predisposition syndromes. J Clin Oncol (2005) 23(2):276–92. 10.1200/JCO.2005.10.042

</cite> [<a href="https://doi.org/10.1200/JCO.2005.10.042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15637391/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Hereditary%20cancer%20predisposition%20syndromes&amp;author=JE%20Garber&amp;author=K%20Offit&amp;volume=23&amp;issue=2&amp;publication_year=2005&amp;pages=276-92&amp;pmid=15637391&amp;doi=10.1200/JCO.2005.10.042&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12">
<span class="label">12.</span><cite>
Rebbeck TR, Friebel TM, Mitra N, Wan F, Chen S, Andrulis IL, et al. 
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women. Breast Cancer Res : BCR (2016) 18(1):112. 10.1186/s13058-016-0768-3

</cite> [<a href="https://doi.org/10.1186/s13058-016-0768-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5106833/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27836010/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res%20:%20BCR&amp;title=Inheritance%20of%20deleterious%20mutations%20at%20both%20BRCA1%20and%20BRCA2%20in%20an%20international%20sample%20of%2032,295%20women&amp;author=TR%20Rebbeck&amp;author=TM%20Friebel&amp;author=N%20Mitra&amp;author=F%20Wan&amp;author=S%20Chen&amp;volume=18&amp;issue=1&amp;publication_year=2016&amp;pages=112&amp;pmid=27836010&amp;doi=10.1186/s13058-016-0768-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13">
<span class="label">13.</span><cite>
Gohil D, Sarker AH, Roy R. Base excision repair: mechanisms and impact in biology, disease, and medicine. Int J Mol Sci (2023) 24(18):14186. 10.3390/ijms241814186

</cite> [<a href="https://doi.org/10.3390/ijms241814186" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10531636/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37762489/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Mol%20Sci&amp;title=Base%20excision%20repair:%20mechanisms%20and%20impact%20in%20biology,%20disease,%20and%20medicine&amp;author=D%20Gohil&amp;author=AH%20Sarker&amp;author=R%20Roy&amp;volume=24&amp;issue=18&amp;publication_year=2023&amp;pages=14186&amp;pmid=37762489&amp;doi=10.3390/ijms241814186&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14">
<span class="label">14.</span><cite>
Hirai Y, Banno K, Suzuki M, Ichikawa Y, Udagawa Y, Sugano K, et al. 
Molecular epidemiological and mutational analysis of DNA mismatch repair (MMR) genes in endometrial cancer patients with HNPCC-associated familial predisposition to cancer. Cancer Sci (2008) 99(9):1715–9. 10.1111/j.1349-7006.2008.00886.x

</cite> [<a href="https://doi.org/10.1111/j.1349-7006.2008.00886.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11159862/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18624996/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Sci&amp;title=Molecular%20epidemiological%20and%20mutational%20analysis%20of%20DNA%20mismatch%20repair%20(MMR)%20genes%20in%20endometrial%20cancer%20patients%20with%20HNPCC-associated%20familial%20predisposition%20to%20cancer&amp;author=Y%20Hirai&amp;author=K%20Banno&amp;author=M%20Suzuki&amp;author=Y%20Ichikawa&amp;author=Y%20Udagawa&amp;volume=99&amp;issue=9&amp;publication_year=2008&amp;pages=1715-9&amp;pmid=18624996&amp;doi=10.1111/j.1349-7006.2008.00886.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15">
<span class="label">15.</span><cite>
Shao C, Wan J, Lam FC, Tang H, Marley AR, Song Y, et al. 
A comprehensive literature review and meta-analysis of the prevalence of pan-cancer BRCA mutations, homologous recombination repair gene mutations, and homologous recombination deficiencies. Environ Mol mutagenesis (2022) 63(6):308–16. 10.1002/em.22505
</cite> [<a href="https://doi.org/10.1002/em.22505" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36054589/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Environ%20Mol%20mutagenesis&amp;title=A%20comprehensive%20literature%20review%20and%20meta-analysis%20of%20the%20prevalence%20of%20pan-cancer%20BRCA%20mutations,%20homologous%20recombination%20repair%20gene%20mutations,%20and%20homologous%20recombination%20deficiencies&amp;author=C%20Shao&amp;author=J%20Wan&amp;author=FC%20Lam&amp;author=H%20Tang&amp;author=AR%20Marley&amp;volume=63&amp;issue=6&amp;publication_year=2022&amp;pages=308-16&amp;pmid=36054589&amp;doi=10.1002/em.22505&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16">
<span class="label">16.</span><cite>
Butz H, Nagy P, Papp J, Bozsik A, Grolmusz VK, Pócza T, et al. 
PALB2 variants extend the mutational profile of Hungarian patients with breast and ovarian cancer. Cancers (2023) 15(17):4350. 10.3390/cancers15174350

</cite> [<a href="https://doi.org/10.3390/cancers15174350" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10487218/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37686625/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=PALB2%20variants%20extend%20the%20mutational%20profile%20of%20Hungarian%20patients%20with%20breast%20and%20ovarian%20cancer&amp;author=H%20Butz&amp;author=P%20Nagy&amp;author=J%20Papp&amp;author=A%20Bozsik&amp;author=VK%20Grolmusz&amp;volume=15&amp;issue=17&amp;publication_year=2023&amp;pages=4350&amp;pmid=37686625&amp;doi=10.3390/cancers15174350&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17">
<span class="label">17.</span><cite>
Slavin TP, Maxwell KN, Lilyquist J, Vijai J, Neuhausen SL, Hart SN, et al. 
The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk. NPJ breast cancer (2017) 3:22. 10.1038/s41523-017-0024-8

</cite> [<a href="https://doi.org/10.1038/s41523-017-0024-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5466608/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28649662/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=NPJ%20breast%20cancer&amp;title=The%20contribution%20of%20pathogenic%20variants%20in%20breast%20cancer%20susceptibility%20genes%20to%20familial%20breast%20cancer%20risk&amp;author=TP%20Slavin&amp;author=KN%20Maxwell&amp;author=J%20Lilyquist&amp;author=J%20Vijai&amp;author=SL%20Neuhausen&amp;volume=3&amp;publication_year=2017&amp;pages=22&amp;pmid=28649662&amp;doi=10.1038/s41523-017-0024-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18">
<span class="label">18.</span><cite>
Tischkowitz M, Balmaña J, Foulkes WD, James P, Ngeow J, Schmutzler R, et al. 
Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med (2021) 23(8):1416–23. 10.1038/s41436-021-01151-8

</cite> [<a href="https://doi.org/10.1038/s41436-021-01151-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33976419/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet%20Med&amp;title=Management%20of%20individuals%20with%20germline%20variants%20in%20PALB2:%20a%20clinical%20practice%20resource%20of%20the%20American%20College%20of%20Medical%20Genetics%20and%20Genomics%20(ACMG)&amp;author=M%20Tischkowitz&amp;author=J%20Balma%C3%B1a&amp;author=WD%20Foulkes&amp;author=P%20James&amp;author=J%20Ngeow&amp;volume=23&amp;issue=8&amp;publication_year=2021&amp;pages=1416-23&amp;pmid=33976419&amp;doi=10.1038/s41436-021-01151-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19">
<span class="label">19.</span><cite>
Graffeo R, Rana HQ, Conforti F, Bonanni B, Cardoso MJ, Paluch-Shimon S, et al. 
Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D. Breast (Edinburgh, Scotland) (2022) 65:32–40. 10.1016/j.breast.2022.06.003

</cite> [<a href="https://doi.org/10.1016/j.breast.2022.06.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9253488/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35772246/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20(Edinburgh,%20Scotland)&amp;title=Moderate%20penetrance%20genes%20complicate%20genetic%20testing%20for%20breast%20cancer%20diagnosis:%20ATM,%20CHEK2,%20BARD1%20and%20RAD51D&amp;author=R%20Graffeo&amp;author=HQ%20Rana&amp;author=F%20Conforti&amp;author=B%20Bonanni&amp;author=MJ%20Cardoso&amp;volume=65&amp;publication_year=2022&amp;pages=32-40&amp;pmid=35772246&amp;doi=10.1016/j.breast.2022.06.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20">
<span class="label">20.</span><cite>
Grafodatskaya D, O'Rielly DD, Bedard K, Butcher DT, Howlett CJ, Lytwyn A, et al. 
Practice guidelines for BRCA1/2 tumour testing in ovarian cancer. J Med Genet (2022) 59(8):727–36. 10.1136/jmedgenet-2021-108238

</cite> [<a href="https://doi.org/10.1136/jmedgenet-2021-108238" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9340048/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35393334/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Med%20Genet&amp;title=Practice%20guidelines%20for%20BRCA1/2%20tumour%20testing%20in%20ovarian%20cancer&amp;author=D%20Grafodatskaya&amp;author=DD%20O'Rielly&amp;author=K%20Bedard&amp;author=DT%20Butcher&amp;author=CJ%20Howlett&amp;volume=59&amp;issue=8&amp;publication_year=2022&amp;pages=727-36&amp;pmid=35393334&amp;doi=10.1136/jmedgenet-2021-108238&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21">
<span class="label">21.</span><cite>
Bouwman P, van der Gulden H, van der Heijden I, Drost R, Klijn CN, Prasetyanti P, et al. 
A high-throughput functional complementation assay for classification of BRCA1 missense variants. Cancer Discov (2013) 3(10):1142–55. 10.1158/2159-8290.CD-13-0094

</cite> [<a href="https://doi.org/10.1158/2159-8290.CD-13-0094" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23867111/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Discov&amp;title=A%20high-throughput%20functional%20complementation%20assay%20for%20classification%20of%20BRCA1%20missense%20variants&amp;author=P%20Bouwman&amp;author=H%20van%20der%20Gulden&amp;author=I%20van%20der%20Heijden&amp;author=R%20Drost&amp;author=CN%20Klijn&amp;volume=3&amp;issue=10&amp;publication_year=2013&amp;pages=1142-55&amp;pmid=23867111&amp;doi=10.1158/2159-8290.CD-13-0094&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22">
<span class="label">22.</span><cite>
Antoniou AC, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. 
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet (2005) 42(7):602–3. 10.1136/jmg.2004.024133

</cite> [<a href="https://doi.org/10.1136/jmg.2004.024133" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1736090/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15994883/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Med%20Genet&amp;title=Breast%20and%20ovarian%20cancer%20risks%20to%20carriers%20of%20the%20BRCA1%205382insC%20and%20185delAG%20and%20BRCA2%206174delT%20mutations:%20a%20combined%20analysis%20of%2022%20population%20based%20studies&amp;author=AC%20Antoniou&amp;author=PD%20Pharoah&amp;author=S%20Narod&amp;author=HA%20Risch&amp;author=JE%20Eyfjord&amp;volume=42&amp;issue=7&amp;publication_year=2005&amp;pages=602-3&amp;pmid=15994883&amp;doi=10.1136/jmg.2004.024133&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23">
<span class="label">23.</span><cite>
Finkelman BS, Rubinstein WS, Friedman S, Friebel TM, Dubitsky S, Schonberger NS, et al. 
Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers. J Clin Oncol (2012) 30(12):1321–8. 10.1200/jco.2011.37.8133

</cite> [<a href="https://doi.org/10.1200/jco.2011.37.8133" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3341145/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22430266/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Breast%20and%20ovarian%20cancer%20risk%20and%20risk%20reduction%20in%20Jewish%20BRCA1/2%20mutation%20carriers&amp;author=BS%20Finkelman&amp;author=WS%20Rubinstein&amp;author=S%20Friedman&amp;author=TM%20Friebel&amp;author=S%20Dubitsky&amp;volume=30&amp;issue=12&amp;publication_year=2012&amp;pages=1321-8&amp;pmid=22430266&amp;doi=10.1200/jco.2011.37.8133&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24">
<span class="label">24.</span><cite>
Fostira F, Saloustros E, Apostolou P, Vagena A, Kalfakakou D, Mauri D, et al. 
Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer. Breast Cancer Res Treat (2018) 169(1):105–13. 10.1007/s10549-018-4661-x

</cite> [<a href="https://doi.org/10.1007/s10549-018-4661-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29335925/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res%20Treat&amp;title=Germline%20deleterious%20mutations%20in%20genes%20other%20than%20BRCA2%20are%20infrequent%20in%20male%20breast%20cancer&amp;author=F%20Fostira&amp;author=E%20Saloustros&amp;author=P%20Apostolou&amp;author=A%20Vagena&amp;author=D%20Kalfakakou&amp;volume=169&amp;issue=1&amp;publication_year=2018&amp;pages=105-13&amp;pmid=29335925&amp;doi=10.1007/s10549-018-4661-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25">
<span class="label">25.</span><cite>
Kluz T, Jasiewicz A, Marczyk E, Jach R, Jakubowska A, Lubiński J, et al. 
Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland. Hereditary Cancer Clin Pract (2018) 16:6. 10.1186/s13053-018-0089-x
</cite> [<a href="https://doi.org/10.1186/s13053-018-0089-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5828315/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29492181/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hereditary%20Cancer%20Clin%20Pract&amp;title=Frequency%20of%20BRCA1%20and%20BRCA2%20causative%20founder%20variants%20in%20ovarian%20cancer%20patients%20in%20South-East%20Poland&amp;author=T%20Kluz&amp;author=A%20Jasiewicz&amp;author=E%20Marczyk&amp;author=R%20Jach&amp;author=A%20Jakubowska&amp;volume=16&amp;publication_year=2018&amp;pages=6&amp;pmid=29492181&amp;doi=10.1186/s13053-018-0089-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26">
<span class="label">26.</span><cite>
Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H, et al. 
Inherited DNA-repair gene mutations in men with metastatic prostate cancer. New Engl J Med (2016) 375(5):443–53. 10.1056/NEJMoa1603144

</cite> [<a href="https://doi.org/10.1056/NEJMoa1603144" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4986616/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27433846/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20Engl%20J%20Med&amp;title=Inherited%20DNA-repair%20gene%20mutations%20in%20men%20with%20metastatic%20prostate%20cancer&amp;author=CC%20Pritchard&amp;author=J%20Mateo&amp;author=MF%20Walsh&amp;author=N%20De%20Sarkar&amp;author=W%20Abida&amp;volume=375&amp;issue=5&amp;publication_year=2016&amp;pages=443-53&amp;pmid=27433846&amp;doi=10.1056/NEJMoa1603144&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27">
<span class="label">27.</span><cite>
Yurgelun MB, Chittenden AB, Morales-Oyarvide V, Rubinson DA, Dunne RF, Kozak MM, et al. 
Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer. Genet Med (2019) 21(1):213–23. 10.1038/s41436-018-0009-5

</cite> [<a href="https://doi.org/10.1038/s41436-018-0009-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6666401/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29961768/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet%20Med&amp;title=Germline%20cancer%20susceptibility%20gene%20variants,%20somatic%20second%20hits,%20and%20survival%20outcomes%20in%20patients%20with%20resected%20pancreatic%20cancer&amp;author=MB%20Yurgelun&amp;author=AB%20Chittenden&amp;author=V%20Morales-Oyarvide&amp;author=DA%20Rubinson&amp;author=RF%20Dunne&amp;volume=21&amp;issue=1&amp;publication_year=2019&amp;pages=213-23&amp;pmid=29961768&amp;doi=10.1038/s41436-018-0009-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28">
<span class="label">28.</span><cite>
Ladopoulou A, Kroupis C, Konstantopoulou I, Ioannidou-Mouzaka L, Schofield AC, Pantazidis A, et al. 
Germ line BRCA1 &amp; BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed. Cancer Lett (2002) 185(1):61–70. 10.1016/s0304-3835(01)00845-x

</cite> [<a href="https://doi.org/10.1016/s0304-3835(01)00845-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12142080/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Lett&amp;title=Germ%20line%20BRCA1%20&amp;%20BRCA2%20mutations%20in%20Greek%20breast/ovarian%20cancer%20families:%205382insC%20is%20the%20most%20frequent%20mutation%20observed&amp;author=A%20Ladopoulou&amp;author=C%20Kroupis&amp;author=I%20Konstantopoulou&amp;author=L%20Ioannidou-Mouzaka&amp;author=AC%20Schofield&amp;volume=185&amp;issue=1&amp;publication_year=2002&amp;pages=61-70&amp;pmid=12142080&amp;doi=10.1016/s0304-3835(01)00845-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29">
<span class="label">29.</span><cite>
Chen S, Francioli LC, Goodrich JK, Collins RL, Kanai M, Wang Q, et al. 
A genomic mutational constraint map using variation in 76,156 human genomes. Nature (2024) 625(7993):92–100. 10.1038/s41586-023-06045-0

</cite> [<a href="https://doi.org/10.1038/s41586-023-06045-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11629659/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38057664/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=A%20genomic%20mutational%20constraint%20map%20using%20variation%20in%2076,156%20human%20genomes&amp;author=S%20Chen&amp;author=LC%20Francioli&amp;author=JK%20Goodrich&amp;author=RL%20Collins&amp;author=M%20Kanai&amp;volume=625&amp;issue=7993&amp;publication_year=2024&amp;pages=92-100&amp;pmid=38057664&amp;doi=10.1038/s41586-023-06045-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30">
<span class="label">30.</span><cite>
Campeau PM, Foulkes WD, Tischkowitz MD. Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet (2008) 124(1):31–42. 10.1007/s00439-008-0529-1

</cite> [<a href="https://doi.org/10.1007/s00439-008-0529-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18575892/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Genet&amp;title=Hereditary%20breast%20cancer:%20new%20genetic%20developments,%20new%20therapeutic%20avenues&amp;author=PM%20Campeau&amp;author=WD%20Foulkes&amp;author=MD%20Tischkowitz&amp;volume=124&amp;issue=1&amp;publication_year=2008&amp;pages=31-42&amp;pmid=18575892&amp;doi=10.1007/s00439-008-0529-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31">
<span class="label">31.</span><cite>
Marmolejo DH, Wong MYZ, Bajalica-Lagercrantz S, Tischkowitz M, Balmaña J, extended ERN-GENTURIS Thematic Group 3. Overview of hereditary breast and ovarian cancer (HBOC) guidelines across Europe. Eur J Med Genet (2021) 64(12):104350. 10.1016/j.ejmg.2021.104350

</cite> [<a href="https://doi.org/10.1016/j.ejmg.2021.104350" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34606975/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Med%20Genet&amp;title=Overview%20of%20hereditary%20breast%20and%20ovarian%20cancer%20(HBOC)%20guidelines%20across%20Europe&amp;author=DH%20Marmolejo&amp;author=MYZ%20Wong&amp;author=S%20Bajalica-Lagercrantz&amp;author=M%20Tischkowitz&amp;author=J%20Balma%C3%B1a&amp;volume=64&amp;issue=12&amp;publication_year=2021&amp;pages=104350&amp;pmid=34606975&amp;doi=10.1016/j.ejmg.2021.104350&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32">
<span class="label">32.</span><cite>
Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, et al. 
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US preventive services task force recommendation statement. Jama (2019) 322(7):652–65. 10.1001/jama.2019.10987

</cite> [<a href="https://doi.org/10.1001/jama.2019.10987" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31429903/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Jama&amp;title=Risk%20assessment,%20genetic%20counseling,%20and%20genetic%20testing%20for%20BRCA-related%20cancer:%20US%20preventive%20services%20task%20force%20recommendation%20statement&amp;author=DK%20Owens&amp;author=KW%20Davidson&amp;author=AH%20Krist&amp;author=MJ%20Barry&amp;author=M%20Cabana&amp;volume=322&amp;issue=7&amp;publication_year=2019&amp;pages=652-65&amp;pmid=31429903&amp;doi=10.1001/jama.2019.10987&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33">
<span class="label">33.</span><cite>
Pashayan N, Antoniou AC, Ivanus U, Esserman LJ, Easton DF, French D, et al. 
Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nat Rev Clin Oncol (2020) 17(11):687–705. 10.1038/s41571-020-0388-9

</cite> [<a href="https://doi.org/10.1038/s41571-020-0388-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7567644/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32555420/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Clin%20Oncol&amp;title=Personalized%20early%20detection%20and%20prevention%20of%20breast%20cancer:%20ENVISION%20consensus%20statement&amp;author=N%20Pashayan&amp;author=AC%20Antoniou&amp;author=U%20Ivanus&amp;author=LJ%20Esserman&amp;author=DF%20Easton&amp;volume=17&amp;issue=11&amp;publication_year=2020&amp;pages=687-705&amp;pmid=32555420&amp;doi=10.1038/s41571-020-0388-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34">
<span class="label">34.</span><cite>
Miller DT, Lee K, Abul-Husn NS, Amendola LM, Brothers K, Chung WK, et al. 
ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med (2022) 24(7):1407–14. 10.1016/j.gim.2022.04.006

</cite> [<a href="https://doi.org/10.1016/j.gim.2022.04.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35802134/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet%20Med&amp;title=ACMG%20SF%20v3.1%20list%20for%20reporting%20of%20secondary%20findings%20in%20clinical%20exome%20and%20genome%20sequencing:%20a%20policy%20statement%20of%20the%20American%20College%20of%20Medical%20Genetics%20and%20Genomics%20(ACMG)&amp;author=DT%20Miller&amp;author=K%20Lee&amp;author=NS%20Abul-Husn&amp;author=LM%20Amendola&amp;author=K%20Brothers&amp;volume=24&amp;issue=7&amp;publication_year=2022&amp;pages=1407-14&amp;pmid=35802134&amp;doi=10.1016/j.gim.2022.04.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35">
<span class="label">35.</span><cite>
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. 
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular Pathology. Genet Med (2015) 17(5):405–24. 10.1038/gim.2015.30

</cite> [<a href="https://doi.org/10.1038/gim.2015.30" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4544753/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25741868/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet%20Med&amp;title=Standards%20and%20guidelines%20for%20the%20interpretation%20of%20sequence%20variants:%20a%20joint%20consensus%20recommendation%20of%20the%20American%20College%20of%20medical%20genetics%20and%20genomics%20and%20the%20association%20for%20molecular%20Pathology&amp;author=S%20Richards&amp;author=N%20Aziz&amp;author=S%20Bale&amp;author=D%20Bick&amp;author=S%20Das&amp;volume=17&amp;issue=5&amp;publication_year=2015&amp;pages=405-24&amp;pmid=25741868&amp;doi=10.1038/gim.2015.30&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36">
<span class="label">36.</span><cite>
Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. 
A method and server for predicting damaging missense mutations. Nat Methods (2010) 7(4):248–9. 10.1038/nmeth0410-248

</cite> [<a href="https://doi.org/10.1038/nmeth0410-248" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2855889/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20354512/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Methods&amp;title=A%20method%20and%20server%20for%20predicting%20damaging%20missense%20mutations&amp;author=IA%20Adzhubei&amp;author=S%20Schmidt&amp;author=L%20Peshkin&amp;author=VE%20Ramensky&amp;author=A%20Gerasimova&amp;volume=7&amp;issue=4&amp;publication_year=2010&amp;pages=248-9&amp;pmid=20354512&amp;doi=10.1038/nmeth0410-248&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37">
<span class="label">37.</span><cite>
Laish I, Friedman E, Levi-Reznick G, Kedar I, Katz L, Levi Z, et al. 
Double heterozygotes of BRCA1/BRCA2 and mismatch repair gene pathogenic variants: case series and clinical implications. Breast Cancer Res Treat (2021) 188(3):685–94. 10.1007/s10549-021-06258-9

</cite> [<a href="https://doi.org/10.1007/s10549-021-06258-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34086170/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res%20Treat&amp;title=Double%20heterozygotes%20of%20BRCA1/BRCA2%20and%20mismatch%20repair%20gene%20pathogenic%20variants:%20case%20series%20and%20clinical%20implications&amp;author=I%20Laish&amp;author=E%20Friedman&amp;author=G%20Levi-Reznick&amp;author=I%20Kedar&amp;author=L%20Katz&amp;volume=188&amp;issue=3&amp;publication_year=2021&amp;pages=685-94&amp;pmid=34086170&amp;doi=10.1007/s10549-021-06258-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38">
<span class="label">38.</span><cite>
Megid TBC, Barros-Filho MC, Pisani JP, Achatz MI. Double heterozygous pathogenic variants prevalence in a cohort of patients with hereditary breast cancer. Front Oncol (2022) 12:873395. 10.3389/fonc.2022.873395

</cite> [<a href="https://doi.org/10.3389/fonc.2022.873395" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9393394/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36003761/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Oncol&amp;title=Double%20heterozygous%20pathogenic%20variants%20prevalence%20in%20a%20cohort%20of%20patients%20with%20hereditary%20breast%20cancer&amp;author=TBC%20Megid&amp;author=MC%20Barros-Filho&amp;author=JP%20Pisani&amp;author=MI%20Achatz&amp;volume=12&amp;publication_year=2022&amp;pages=873395&amp;pmid=36003761&amp;doi=10.3389/fonc.2022.873395&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39">
<span class="label">39.</span><cite>
Vos JR, Giepmans L, Röhl C, Geverink N, Hoogerbrugge N, ERN GENTURIS. Boosting care and knowledge about hereditary cancer: European reference Network on genetic tumour risk syndromes. Fam Cancer (2019) 18(2):281–4. 10.1007/s10689-018-0110-6

</cite> [<a href="https://doi.org/10.1007/s10689-018-0110-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6449296/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30302652/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Fam%20Cancer&amp;title=Boosting%20care%20and%20knowledge%20about%20hereditary%20cancer:%20European%20reference%20Network%20on%20genetic%20tumour%20risk%20syndromes&amp;author=JR%20Vos&amp;author=L%20Giepmans&amp;author=C%20R%C3%B6hl&amp;author=N%20Geverink&amp;author=N%20Hoogerbrugge&amp;volume=18&amp;issue=2&amp;publication_year=2019&amp;pages=281-4&amp;pmid=30302652&amp;doi=10.1007/s10689-018-0110-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/11324426/bin/DataSheet1.docx" data-ga-action="click_feat_suppl" class="usa-link">DataSheet1.docx</a><sup> (28.4KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<a href="#s11" class="usa-link">Supplementary Material</a>.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Pathology and Oncology Research are provided here courtesy of <strong>Frontiers Media SA</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3389/pore.2024.1611813"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/pore-30-1611813.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (652.8 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/11324426/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/11324426/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11324426%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC11324426/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC11324426/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC11324426/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/39148954/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC11324426/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/39148954/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC11324426/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/11324426/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="6bIm7UQldIIB2eN5wJQevJxdrM3zDzynIl8zTMjTuqcVdki6MIeO2RqTyEsMGk3S">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
